ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 816

Glomerular Filtration Rate, Chronic Kidney Disease and Incidence of Physician Diagnosed Gout

Eswar Krishnan, Medicine, Standford University, Palo Alto, CA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: gout, longitudinal studies, Renal disease, risk assessment and uric acid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Metabolic and Crystal Arthropathies: Clinical

Session Type: Abstract Submissions (ACR)

Background/Purpose: The kidney is the major organ of urate excretion in humans. Yet, there are few studies that assess whether reduced glomerular filtration and/or kidney damage increases the incidence of gout.

Methods: Seven-year follow up data from the Multiple Risk Factor Intervention Trial, a primary prevention trial for cardiovascular disease among 12,886 men aged 35 to 57 years were analyzed. At each of seven annual visits, participants were assessed for gout by the study physician. Chronic kidney disease was defined as per the National Kidney Foundation guidelines. Standardized incidence ratios (SIR) we computed using data from the Rochester Epidemiology Project.  Cox proportional hazards regression analysis was used to assess the association between gout and chronic kidney disease after accounting for the effects of potential confounders (age, race, blood pressure, alcohol and fructose consumption, body mass index, fasting triglycerides, use of aspirin, diabetes status, and diuretic use).

Results: Overall there were 722 cases of incident gout over 76,602 person-years of follow up. The incidence and SIR of gout  increased with decreasing eGFR (Figure). The multivariable adjusted hazard ratio for those with chronic kidney disease was 1.9 (1.6, 2.2). Each standard deviation decline in eGFR was associated with a hazard ratio of 1.4 (1.3, 1.5).  Addition of serum urate as well as urate-chronic kidney disease interaction term did not attenuate the hazard ratio.

Conclusion:   Chronic kidney disease is an independent risk factor for gout. The large magnitude of the metrics of association was not explained by hyperuricemia associated with chronic kidney disease.

Description: U:IyerConferencesACR MEETING 2012AbstractsGlomerular Filtration Rate CKD and Gout (MRFIT) ACR 2012 abstract_filesimage001.jpg

 


Disclosure:

E. Krishnan,

savient,

1,

URL, takeda, metbolex,ARDEA,

2,

METABOLEX TAKEDA,

5;

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/glomerular-filtration-rate-chronic-kidney-disease-and-incidence-of-physician-diagnosed-gout/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology